SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kilitch Drugs(India) - Quaterly Results

26 May 2022 Evaluate
The turnover is pegged at Rs. 320.31 millions for the March 2022 quarter. The mentioned figure indicates a rise of about 51.49% as against Rs. 211.44 millions during the year-ago period.The Total revenue for the quarter ended March 2022 of  Rs. 30.24  millions  grew by 250.41% from Rs. 8.63 millions.OP of the company witnessed a marginal growth to 47.45 millions from 17.78 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 320.31 211.44 51.49 1051.60 700.17 50.19 1051.60 700.17 50.19
Other Income 7.68 13.38 -42.60 45.59 41.94 8.70 45.59 41.94 8.70
PBIDT 47.45 17.78 166.87 155.55 94.04 65.41 155.55 94.04 65.41
Interest 1.77 1.62 9.26 6.63 7.54 -12.07 6.63 7.54 -12.07
PBDT 45.68 16.16 182.67 148.92 86.50 72.16 148.92 86.50 72.16
Depreciation 2.59 2.92 -11.30 9.64 11.41 -15.51 9.64 11.41 -15.51
PBT 43.09 13.24 225.45 139.28 75.09 85.48 139.28 75.09 85.48
TAX 12.85 4.61 178.74 34.01 13.53 151.37 34.01 13.53 151.37
Deferred Tax -1.45 2.06 -170.39 -2.33 -3.13 -25.56 -2.33 -3.13 -25.56
PAT 30.24 8.63 250.41 105.27 61.56 71.00 105.27 61.56 71.00
Equity 155.82 154.95 0.56 155.82 154.95 0.56 155.82 154.95 0.56
PBIDTM(%) 14.81 8.41 76.17 14.79 13.43 10.13 14.79 13.43 10.13

Kilitch Drugs(India) Share Price

135.10 4.55 (3.49%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×